- Home
- CVR vs BCDA Comparison
CVR vs BCDA Comparison
Compare CVR & BCDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVR
- BCDA
- Stock Information
- Founded
- CVR 1920
- BCDA N/A
- Country
- CVR United States
- BCDA United States
- Employees
- CVR N/A
- BCDA N/A
- Industry
- CVR Industrial Machinery/Components
- BCDA Biotechnology: Pharmaceutical Preparations
- Sector
- CVR Industrials
- BCDA Health Care
- Exchange
- CVR Nasdaq
- BCDA Nasdaq
- Market Cap
- CVR 11.1M
- BCDA 11.3M
- IPO Year
- CVR N/A
- BCDA N/A
- Fundamental
- Price
- CVR $9.52
- BCDA $2.01
- Analyst Decision
- CVR
- BCDA Strong Buy
- Analyst Count
- CVR 0
- BCDA 1
- Target Price
- CVR N/A
- BCDA $25.00
- AVG Volume (30 Days)
- CVR 1.0K
- BCDA 74.5K
- Earning Date
- CVR 08-08-2025
- BCDA 08-11-2025
- Dividend Yield
- CVR 1.26%
- BCDA N/A
- EPS Growth
- CVR N/A
- BCDA N/A
- EPS
- CVR N/A
- BCDA N/A
- Revenue
- CVR $25,617,681.00
- BCDA N/A
- Revenue This Year
- CVR N/A
- BCDA N/A
- Revenue Next Year
- CVR N/A
- BCDA N/A
- P/E Ratio
- CVR N/A
- BCDA N/A
- Revenue Growth
- CVR N/A
- BCDA N/A
- 52 Week Low
- CVR $8.15
- BCDA $1.63
- 52 Week High
- CVR $22.27
- BCDA $3.26
- Technical
- Relative Strength Index (RSI)
- CVR 28.40
- BCDA 55.51
- Support Level
- CVR $9.50
- BCDA $1.90
- Resistance Level
- CVR $10.12
- BCDA $1.99
- Average True Range (ATR)
- CVR 0.25
- BCDA 0.08
- MACD
- CVR -0.16
- BCDA 0.03
- Stochastic Oscillator
- CVR 12.21
- BCDA 96.15
About CVR Chicago Rivet & Machine Co.
Chicago Rivet & Machine Co is in the fastener industry in North America. The company operates in two segments namely fasteners and assembly equipment. Its fastener segment consists of the manufacture and sale of rivets, cold-formed fasteners, parts, and screw machine products. The assembly equipment segment consists mainly of the manufacture of automatic rivet setting machines, automatic assembly equipment, and parts and tools for such machines. The majority of revenue is from the fastener segment.
About BCDA BioCardia Inc.
BioCardia Inc is a clinical-stage company developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases with unmet medical needs. Its two cell therapy platforms derived from the bone marrow. CardiAMP autologous mononuclear cell therapy platform is being advanced for two clinical indications: ischemic heart failure with reduced ejection fraction (HFrEF) and refractory angina resulting from chronic myocardial ischemia (CMI). Its immunomodulatory allogeneic mesenchymal stem cell (MSC) therapy platform is being an off the shelf cell therapy for two clinical indications: the treatment of ischemic HFrEF (CardiALLO), which is actively enrolling, and acute respiratory distress syndrome (ARDS).